PERCEPTIVE ADVISORS LLC 13D and 13G filings for Rhythm Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 9:50 pm Purchase |
2024-09-30 | 13G | Rhythm Pharmaceuticals, Inc. RYTM |
PERCEPTIVE ADVISORS LLC | 5,435,210 8.600% |
291,635 (+5.67%) |
Filing |
| 2024-04-17 4:15 pm Purchase |
2024-04-15 | 13D | Rhythm Pharmaceuticals, Inc. RYTM |
PERCEPTIVE ADVISORS LLC | 5,143,575 8.300% |
1,874,996 (+57.36%) |
Filing |
| 2024-04-03 6:18 pm Unchanged |
2024-04-01 | 13D | Rhythm Pharmaceuticals, Inc. RYTM |
PERCEPTIVE ADVISORS LLC | 3,268,579 5.400% |
0 (Unchanged) |
Filing |
| 2024-03-20 5:51 pm Purchase |
2024-03-13 | 13D | Rhythm Pharmaceuticals, Inc. RYTM |
PERCEPTIVE ADVISORS LLC | 3,268,579 5.400% |
8,566 (+0.26%) |
Filing |
| 2024-02-12 4:16 pm Purchase |
2024-02-01 | 13G | Rhythm Pharmaceuticals, Inc. RYTM |
PERCEPTIVE ADVISORS LLC | 3,260,013 5.500% |
3,260,013 (New Position) |
Filing |